Journal of Antimicrobial Chemotherapy (1987) 20, 323-334
© 1987 The British Society for Antimicrobial Chemotherapy
research-article |
Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel ß-lactamase
aService de Bactériologie, Faculté de Médecine 28 place Henri Dunant, 63001 Clermont-Ferrand bMusèum National d'Histoire Naturelle CNRS UA 401,63, rue Buffon, 75231 Paris Cedex 05 cUnité des Agents Antibactériens CNRS UA 271, Institut Pasteur, 75724 Paris Cedex 15, France
Received 9 March 1987;
*Corresponding author
Approximately 10% (89 isolates) of Klebsiella pneumoniae isolated in 1985 from patients in intensive care units in Clermont-Ferrand exhibited a complex resistance phenotype towards antibiotics. They were resistant to amino-, carboxy- and ureidopenicillins, aminoglycosides (except gentamicin), chloramphenicol, sulphonamides, tetracyclines and, most importantly, to cephalosporins (except cefoxitin and latamoxef) and to aztreonam. The metabolic profile of fifty isolates was identical and seven were selected for further study. All the resistance characters in these isolates were transferable to Escherichia coli by conjugation and were lost en bloc after treatment with ethidium bromide. Agarose gel electrophoresis of crude lysates of the wild types and their transconjugants indicated that the multiple resistances were mediated by a 95kb plasmid, pCF04. The seven isolates selected for study and their corresponding transconjugants, constitutively produced a plasmid-mediated ß-lactamase with a pI of 6.3 that was much more active against third-generation cephalosporins than against cephalothin. The substrate profile and the isoelectric-focusing behaviour of this enzyme differed from those of other known plasmid-mediated ß-lactamases, and the enzyme was designated CTX-1. A chromosomally-encoded SHV-1 (PIT-2) penicillinase (pI 7.7) was also present in the seven K. pneumoniae isolates but did not transfer. Resistance to aminoglycosides in the K. pneumoniae isolates was due to synthesis of a 6'-aminoglycoside acetyltransferase type IV. Our data indicate an epidemic of antibiotic multiply-resistant strains of K. pneumoniae producing a new ß-lactamase.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. H. Jones, A. Ruzin, M. Tuckman, M. A. Visalli, P. J. Petersen, and P. A. Bradford Pyrosequencing Using the Single-Nucleotide Polymorphism Protocol for Rapid Determination of TEM- and SHV-Type Extended-Spectrum {beta}-Lactamases in Clinical Isolates and Identification of the Novel {beta}-Lactamase Genes blaSHV-48, blaSHV-105, and blaTEM-155 Antimicrob. Agents Chemother., March 1, 2009; 53(3): 977 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Mroczkowska and M. Barlow Fitness Trade-Offs in blaTEM Evolution Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2340 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brasme, P. Nordmann, F. Fidel, M. F. Lartigue, O. Bajolet, L. Poirel, D. Forte, V. Vernet-Garnier, J. Madoux, J. C. Reveil, et al. Incidence of class A extended-spectrum {beta}-lactamases in Champagne-Ardenne (France): a 1 year prospective study J. Antimicrob. Chemother., November 1, 2007; 60(5): 956 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Perilli, G. Celenza, M. Fiore, B. Segatore, C. Pellegrini, F. Luzzaro, G. M. Rossolini, and G. Amicosante Biochemical analysis of TEM-134, a new TEM-type extended-spectrum {beta}-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital J. Antimicrob. Chemother., October 1, 2007; 60(4): 877 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Robin, J. Delmas, C. Schweitzer, O. Tournilhac, O. Lesens, C. Chanal, and R. Bonnet Evolution of TEM-Type Enzymes: Biochemical and Genetic Characterization of Two New Complex Mutant TEM Enzymes, TEM-151 and TEM-152, from a Single Patient Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1304 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. al Naiemi, B. Duim, and A. Bart A CTX-M extended-spectrum {beta}-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J. Med. Microbiol., November 1, 2006; 55(Pt 11): 1607 - 1608. [Full Text] [PDF] |
||||
![]() |
F. Robin, J. Delmas, M. Archambaud, C. Schweitzer, C. Chanal, and R. Bonnet CMT-Type {beta}-Lactamase TEM-125, an Emerging Problem for Extended-Spectrum {beta}-Lactamase Detection. Antimicrob. Agents Chemother., July 1, 2006; 50(7): 2403 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Anderson, J. J. Engemann, L. J. Harrell, Y. Carmeli, L. B. Reller, and K. S. Kaye Predictors of Mortality in Patients with Bloodstream Infection Due to Ceftazidime-Resistant Klebsiella pneumoniae. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1715 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Jacoby {beta}-Lactamase Nomenclature. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1123 - 1129. [Full Text] [PDF] |
||||
![]() |
F. Robin, J. Delmas, C. Chanal, D. Sirot, J. Sirot, and R. Bonnet TEM-109 (CMT-5), a Natural Complex Mutant of TEM-1 {beta}-Lactamase Combining the Amino Acid Substitutions of TEM-6 and TEM-33 (IRT-5) Antimicrob. Agents Chemother., November 1, 2005; 49(11): 4443 - 4447. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Paterson and R. A. Bonomo Extended-Spectrum {beta}-Lactamases: a Clinical Update Clin. Microbiol. Rev., October 1, 2005; 18(4): 657 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Delmas, F. Robin, F. Bittar, C. Chanal, and R. Bonnet Unexpected Enzyme TEM-126: Role of Mutation Asp179Glu Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4280 - 4287. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. De Champs, C. Chanal, D. Sirot, R. Baraduc, J. P. Romaszko, R. Bonnet, A. Plaidy, M. Boyer, E. Carroy, M. C. Gbadamassi, et al. Frequency and diversity of Class A extended-spectrum {beta}-lactamases in hospitals of the Auvergne, France: a 2 year prospective study J. Antimicrob. Chemother., September 1, 2004; 54(3): 634 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bonnet Growing Group of Extended-Spectrum {beta}-Lactamases: the CTX-M Enzymes Antimicrob. Agents Chemother., January 1, 2004; 48(1): 1 - 14. [Full Text] [PDF] |
||||
![]() |
A. M. Queenan, B. Foleno, C. Gownley, E. Wira, and K. Bush Effects of Inoculum and {beta}-Lactamase Activity in AmpC- and Extended-Spectrum {beta}-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella pneumoniae Clinical Isolates Tested by Using NCCLS ESBL Methodology J. Clin. Microbiol., January 1, 2004; 42(1): 269 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Paterson, K. M. Hujer, A. M. Hujer, B. Yeiser, M. D. Bonomo, L. B. Rice, R. A. Bonomo, and the International Klebsiella Study Group, Extended-Spectrum {beta}-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type {beta}-Lactamases Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3554 - 3560. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Morris, C. O'Hare, M. Glennon, M. Maher, G. Corbett-Feeney, and M. Cormican Extended-Spectrum {beta}-Lactamases in Ireland, Including a Novel Enzyme, TEM-102 Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2572 - 2578. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jain, I. Roy, M. K. Gupta, M. Kumar, and S. K. Agarwal Prevalence of extended-spectrum {beta}-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital J. Med. Microbiol., May 1, 2003; 52(5): 421 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Neuwirth, S. Madec, E. Siebor, A. Pechinot, J.-M. Duez, M. Pruneaux, M. Fouchereau-Peron, A. Kazmierczak, and R. Labia TEM-89 beta -Lactamase Produced by a Proteus mirabilis Clinical Isolate: New Complex Mutant (CMT 3) with Mutations in both TEM-59 (IRT-17) and TEM-3 Antimicrob. Agents Chemother., December 1, 2001; 45(12): 3591 - 3594. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. de Champs, C. Monne, R. Bonnet, W. Sougakoff, D. Sirot, C. Chanal, and J. Sirot New TEM Variant (TEM-92) Produced by Proteus mirabilis and Providencia stuartii Isolates Antimicrob. Agents Chemother., April 1, 2001; 45(4): 1278 - 1280. [Abstract] [Full Text] |
||||
![]() |
A. Oliver, J. C. Pérez-Díaz, T. M. Coque, F. Baquero, and R. Cantón Nucleotide Sequence and Characterization of a Novel Cefotaxime-Hydrolyzing {beta}-Lactamase (CTX-M-10) Isolated in Spain Antimicrob. Agents Chemother., February 1, 2001; 45(2): 616 - 620. [Abstract] [Full Text] |
||||
![]() |
R. Bonnet, J. L. M. Sampaio, C. Chanal, D. Sirot, C. De Champs, J. L. Viallard, R. Labia, and J. Sirot A Novel Class A Extended-Spectrum beta -Lactamase (BES-1) in Serratia marcescens Isolated in Brazil Antimicrob. Agents Chemother., November 1, 2000; 44(11): 3061 - 3068. [Abstract] [Full Text] |
||||
![]() |
C. Chanal, R. Bonnet, C. De Champs, D. Sirot, R. Labia, and J. Sirot Prevalence of beta -Lactamases among 1,072 Clinical Strains of Proteus mirabilis: a 2-Year Survey in a French Hospital Antimicrob. Agents Chemother., July 1, 2000; 44(7): 1930 - 1935. [Abstract] [Full Text] |
||||
![]() |
R. Bonnet, J. L. M. Sampaio, R. Labia, C. De Champs, D. Sirot, C. Chanal, and J. Sirot A Novel CTX-M beta -Lactamase (CTX-M-8) in Cefotaxime-Resistant Enterobacteriaceae Isolated in Brazil Antimicrob. Agents Chemother., July 1, 2000; 44(7): 1936 - 1942. [Abstract] [Full Text] |
||||
![]() |
A. Rosenau, B. Cattier, N. Gousset, P. Harriau, A. Philippon, and R. Quentin Capnocytophaga ochracea: Characterization of a Plasmid-Encoded Extended-Spectrum TEM-17 beta -Lactamase in the Phylum Flavobacter-Bacteroides Antimicrob. Agents Chemother., March 1, 2000; 44(3): 760 - 762. [Abstract] [Full Text] |
||||
![]() |
R. Bonnet, C. De Champs, D. Sirot, C. Chanal, R. Labia, and J. Sirot Diversity of TEM Mutants in Proteus mirabilis Antimicrob. Agents Chemother., November 1, 1999; 43(11): 2671 - 2677. [Abstract] [Full Text] |
||||
![]() |
G. Arlet, S. Goussard, P. Courvalin, and A. Philippon Sequences of the Genes for the TEM-20, TEM-21, TEM-22, and TEM-29 Extended-Spectrum beta -Lactamases Antimicrob. Agents Chemother., April 1, 1999; 43(4): 969 - 971. [Abstract] [Full Text] |
||||
![]() |
M. Gniadkowski and W. Hryniewicz Outbreak of Ceftazidime-Resistant Klebsiella pneumoniae in a Pediatric Hospital in Warsaw, Poland: Clonal Spread of the TEM-47 Extended-Spectrum beta -Lactamase (ESBL)-Producing Strain and Transfer of a Plasmid Carrying the SHV-5-Like ESBL-Encoding Gene Antimicrob. Agents Chemother., December 1, 1998; 42(12): 3079 - 3085. [Abstract] [Full Text] |
||||
![]() |
C. Poyart, P. Mugnier, G. Quesne, P. Berche, and P. Trieu-Cuot A Novel Extended-Spectrum TEM-Type beta -Lactamase (TEM-52) Associated with Decreased Susceptibility to Moxalactam in Klebsiella pneumoniae Antimicrob. Agents Chemother., January 1, 1998; 42(1): 108 - 113. [Abstract] [Full Text] |
||||
![]() |
C. Brun-Buisson, P. Legrand, A. Rauss, C. Richard, F. Montravers, M. Besbes, J. L. Meakins, C. J. Soussy, and F. Lemaire Intestinal Decontamination for Control of Nosocomial Multiresistant Gram-Negative Bacilli: Study of an Outbreak in an Intensive Care Unit Ann Intern Med, June 1, 1989; 110(11): 873 - 881. [Abstract] [PDF] |
||||





